Page last updated: 2024-08-17

quinoxalines and Ambulation Disorders, Neurologic

quinoxalines has been researched along with Ambulation Disorders, Neurologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leung, LS; Ma, J1

Other Studies

1 other study(ies) available for quinoxalines and Ambulation Disorders, Neurologic

ArticleYear
The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
    Psychopharmacology, 2007, Volume: 191, Issue:4

    Topics: Acoustic Stimulation; Animals; Behavior, Animal; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; GABA Agonists; Gait; Gait Disorders, Neurologic; Hippocampus; Ketamine; Locomotion; Male; Mammillary Bodies; Muscimol; Neural Pathways; Quinoxalines; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Septal Nuclei; Time Factors

2007